13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13G Filed 2026-06-18 Event — SEC 0001213900-26-070194 →

Soleus Capital Master Fund, L.P. BIODESIX INC BDSX

Stake: Shares: CUSIP: 09075X207 Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
7 13D/G filings on this issuer
6 other filings besides this one
Filer Track Record
4 filings by this filer
3 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 2.19
167,970 shares short · +59.3% vs prior

Other 13D/G Filings on BIODESIX INC

FiledFormFilerStakeShares
2026-01-27 SCHEDULE SCHULER JACK W 24.00% 2,333,945 view →
2025-09-23 SCHEDULE SCHULER JACK W 27.00% 2,151,480 view →
2025-09-03 SCHEDULE SCHULER JACK W 26.00% 39,821,357 view →
2025-05-20 SCHEDULE SCHULER JACK W 24.70% 36,332,985 view →
2023-08-11 SC SCHULER JACK W view →
2022-01-04 SC SCHULER JACK W view →

Other Filings by Soleus Capital Master Fund, L.P.

FiledFormIssuerStakeShares
2026-05-27 SCHEDULE 13G INSPIRE MEDICAL SYSTEMS, INC. INSP view →
2025-07-21 SCHEDULE ESSA Pharma Inc. 9.80% 4,362,026 view →
2025-04-11 SCHEDULE Theratechnologies Inc. 10.40% 4,801,375 view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →